Tomás Lúcas

1.0k total citations
18 papers, 738 citations indexed

About

Tomás Lúcas is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Epidemiology. According to data from OpenAlex, Tomás Lúcas has authored 18 papers receiving a total of 738 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Surgery and 4 papers in Epidemiology. Recurrent topics in Tomás Lúcas's work include Pituitary Gland Disorders and Treatments (17 papers), Growth Hormone and Insulin-like Growth Factors (11 papers) and Adrenal and Paraganglionic Tumors (10 papers). Tomás Lúcas is often cited by papers focused on Pituitary Gland Disorders and Treatments (17 papers), Growth Hormone and Insulin-like Growth Factors (11 papers) and Adrenal and Paraganglionic Tumors (10 papers). Tomás Lúcas collaborates with scholars based in Spain. Tomás Lúcas's co-authors include Javier Solis Estrada, B. Barceló, Santiágo Díez, Isabel Millán, Mauro Boronat, Rosa Magallón-Botaya, Mónica Marazuela, Ignacio Bernabéu, Miguel Catalá and R. Astorga and has published in prestigious journals such as New England Journal of Medicine, The Journal of Clinical Endocrinology & Metabolism and Clinical Endocrinology.

In The Last Decade

Tomás Lúcas

18 papers receiving 714 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomás Lúcas Spain 13 690 328 151 143 51 18 738
B. Barceló Spain 10 616 0.9× 310 0.9× 143 0.9× 126 0.9× 26 0.5× 18 651
Raquel S. Jallad Brazil 17 651 0.9× 268 0.8× 80 0.5× 181 1.3× 58 1.1× 42 723
Elena V Varlamov United States 14 522 0.8× 246 0.8× 85 0.6× 100 0.7× 43 0.8× 28 602
Luiz Eduardo Wildemberg Brazil 21 936 1.4× 449 1.4× 184 1.2× 298 2.1× 114 2.2× 52 1.0k
Marcos Manavela Argentina 12 531 0.8× 261 0.8× 61 0.4× 70 0.5× 68 1.3× 26 588
Christine Cortet France 12 392 0.6× 161 0.5× 86 0.6× 73 0.5× 61 1.2× 17 498
Cristina Lamas Spain 15 504 0.7× 343 1.0× 97 0.6× 130 0.9× 47 0.9× 61 626
Luiz Roberto Salgado Brazil 9 764 1.1× 360 1.1× 88 0.6× 163 1.1× 45 0.9× 16 839
Elisa Verrua Italy 15 384 0.6× 158 0.5× 65 0.4× 77 0.5× 106 2.1× 29 508
Hélène Lasolle France 13 444 0.6× 201 0.6× 193 1.3× 137 1.0× 62 1.2× 38 523

Countries citing papers authored by Tomás Lúcas

Since Specialization
Citations

This map shows the geographic impact of Tomás Lúcas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomás Lúcas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomás Lúcas more than expected).

Fields of papers citing papers by Tomás Lúcas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomás Lúcas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomás Lúcas. The network helps show where Tomás Lúcas may publish in the future.

Co-authorship network of co-authors of Tomás Lúcas

This figure shows the co-authorship network connecting the top 25 collaborators of Tomás Lúcas. A scholar is included among the top collaborators of Tomás Lúcas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomás Lúcas. Tomás Lúcas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Puig‐Domingo, Manel, Alfonso Soto, Eva Venegas, et al.. (2016). Use of lanreotide in combination with cabergoline or pegvisomant in patients with acromegaly in the clinical practice: The ACROCOMB study. Endocrinología y Nutrición. 63(8). 397–408. 20 indexed citations
2.
Puig‐Domingo, Manel, Alfonso Soto, Eva Venegas, et al.. (2016). Use of lanreotide in combination with cabergoline or pegvisomant in patients with acromegaly in the clinical practice: The ACROCOMB study. Endocrinología y Nutrición (English Edition). 63(8). 397–408. 3 indexed citations
3.
Lecumberri, Beatriz, Javier Solis Estrada, José García-Uría, et al.. (2015). Neurocognitive long-term impact of two-field conventional radiotherapy in adult patients with operated pituitary adenomas. Pituitary. 18(6). 782–795. 17 indexed citations
4.
Ramos‐Leví, Ana M., Ignacio Bernabéu, Cristina Álvarez‐Escolá, et al.. (2015). Long‐term treatment with pegvisomant for acromegaly: a 10‐year experience. Clinical Endocrinology. 84(4). 540–550. 11 indexed citations
5.
Ramos‐Leví, Ana M., Mónica Marazuela, Celsa Quinteiro, et al.. (2014). Analysis of IGF(CA)19 and IGFBP3-202A/C gene polymorphisms in patients with acromegaly: association with clinical presentation and response to treatments. European Journal of Endocrinology. 172(2). 115–122. 12 indexed citations
6.
Bernabéu, Ignacio, Concepción Blanco, Fernando Cordido, et al.. (2013). Efficacy and safety of lanreotide in combination with cabergoline in clinical practice in patients with active acromegaly with monotherapy failure. Endocrine Abstracts. 1 indexed citations
7.
Oriola, Josep, Tomás Lúcas, Irene Halperín, et al.. (2012). Germline mutations of AIP gene in somatotropinomas resistant to somatostatin analogues. European Journal of Endocrinology. 168(1). 9–13. 50 indexed citations
8.
Halperín, Irene, Javier Aller, C Varela, et al.. (2012). No clinically significant valvular regurgitation in long‐term cabergoline treatment for prolactinoma. Clinical Endocrinology. 77(2). 275–280. 22 indexed citations
9.
Bernabéu, Ignacio, Mónica Marazuela, Tomás Lúcas, et al.. (2010). Pegvisomant-Induced Liver Injury Is Related to the UGT1A1*28 Polymorphism of Gilbert’s Syndrome. The Journal of Clinical Endocrinology & Metabolism. 95(5). 2147–2154. 37 indexed citations
10.
Bernabéu, Ignacio, Cristina Álvarez‐Escolá, Celsa Quinteiro, et al.. (2009). The Exon 3-Deleted Growth Hormone Receptor Is Associated with Better Response to Pegvisomant Therapy in Acromegaly. The Journal of Clinical Endocrinology & Metabolism. 95(1). 222–229. 48 indexed citations
11.
Marazuela, Mónica, Tomás Lúcas, Cristina Álvarez‐Escolá, et al.. (2009). Long-term treatment of acromegalic patients resistant to somatostatin analogues with the GH receptor antagonist pegvisomant: its efficacy in relation to gender and previous radiotherapy. European Journal of Endocrinology. 160(4). 535–542. 50 indexed citations
12.
Granada, María Luisa, Àngels Ulied, Felipe F. Casanueva, et al.. (2007). Serum IGF‐I measured by four different immunoassays in patients with adult GH deficiency or acromegaly and in a control population. Clinical Endocrinology. 68(6). 942–950. 33 indexed citations
13.
Lamas, Cristina, et al.. (2004). Malignant prolactinoma with multiple bone and pulmonary metastases. Journal of Neurosurgery Pediatrics. 101(2). 116–121. 10 indexed citations
14.
Lúcas, Tomás, R. Astorga, & Miguel Catalá. (2003). Preoperative lanreotide treatment for GH‐secreting pituitary adenomas: effect on tumour volume and predictive factors of significant tumour shrinkage. Clinical Endocrinology. 58(4). 471–481. 55 indexed citations
15.
Estrada, Javier Solis, José García-Uría, Cristina Lamas, et al.. (2001). The Complete Normalization of the Adrenocortical Function as the Criterion of Cure after Transsphenoidal Surgery for Cushing’s Disease. The Journal of Clinical Endocrinology & Metabolism. 86(12). 5695–5699. 82 indexed citations
16.
Estrada, Javier Solis, Mauro Boronat, Rosa Magallón-Botaya, et al.. (1997). The Long-Term Outcome of Pituitary Irradiation after Unsuccessful Transsphenoidal Surgery in Cushing's Disease. New England Journal of Medicine. 336(3). 172–177. 255 indexed citations
17.
Boronat, Mauro, et al.. (1996). Cushing’s syndrome due to autonomous macronodular adrenal hyperplasia: long-term follow-up after unilateral adrenalectomy. Postgraduate Medical Journal. 72(852). 614–616. 15 indexed citations
18.
Marazuela, Mónica, et al.. (1995). Impaired natural killer cytotoxicity in peripheral blood mononuclear cells in Graves' disease. European Journal of Endocrinology. 132(2). 175–180. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B. Barceló Breakdown of academic impact, for papers by Raquel S. Jallad Breakdown of academic impact, for papers by Elena V Varlamov Breakdown of academic impact, for papers by Luiz Eduardo Wildemberg Breakdown of academic impact, for papers by Marcos Manavela Breakdown of academic impact, for papers by Christine Cortet Breakdown of academic impact, for papers by Cristina Lamas Breakdown of academic impact, for papers by Luiz Roberto Salgado Breakdown of academic impact, for papers by Elisa Verrua Breakdown of academic impact, for papers by Hélène Lasolle
Rankless by CCL
2026